Kathrin Reinhardt

InterMed Discovery is an emerging world class Natural Product lead-discovery company, driving innovation through the generation of novel product candidates for the life science, food and cosmetics industries. Using one of the most powerful validated Natural Product discovery engines, InterMed Discovery generates proprietary product pipelines of early stage pharmaceuticals and functional ingredients and also supports partners in research and lead generation. Biologically characterized product leads are identified using IMD Bioprofiling and NPsilico, which together comprise a proprietary bioinformatics platform drawing on screening results compiled over many years, complemented by primary biological and chemical research on Natural Products. InterMed Discovery adds to this the industry's largest collections of pure compounds, sample fractions and mixtures as its source for potential Natural Product LEADs. The Company is located in Dortmund, Germany and was founded in 2006 as a Management-Buy-Out of the Natural Products Research Unit of BAYER HealthCare AG. This heritage within a major pharmaceutical company means that, although a new company, InterMed Discovery started life with a highly experienced senior staff as well as the unique sample libraries and data bases drawing on over 20 years of Natural Product research. Presently, InterMed Discovery comprises a total staff of 30 with 16 members dedicated to research. The laboratories at the BioTech Center (BMZ) in Dortmund contain libraries of more than 150,000 screening samples, compounds, and production facilities for micro- to multi-gram scales.